Triptolide-eluting stent prevents porcine coronary artery in-stent restenosis by affecting PCNA and P27(kip1) expression.
- Author:
Dong-feng LU
1
;
Jing HUANG
;
Hao WU
;
Xiao YUAN
;
Li ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Anti-Inflammatory Agents, Non-Steroidal; therapeutic use; Coronary Restenosis; prevention & control; Coronary Vessels; drug effects; metabolism; pathology; Cyclin-Dependent Kinase Inhibitor p27; biosynthesis; Diterpenes; therapeutic use; Drug-Eluting Stents; Epoxy Compounds; therapeutic use; Immunohistochemistry; Male; Phenanthrenes; therapeutic use; Proliferating Cell Nuclear Antigen; biosynthesis; Random Allocation; Swine; Time Factors; Tunica Intima; drug effects; metabolism; pathology
- From: Journal of Southern Medical University 2007;27(5):667-670
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effectiveness and safety of triptolide-eluting stents implanted in porcine coronary arteries for restenosis prevention, and its effect on the expression of proliferating cell nuclear antigen (PCNA) and P27(kip1).
METHODSTen triptolide-eluting stents and 10 stainless steel stents (control) were implanted in 20 porcine coronary arteries at random. Four weeks later, angiography of the arteries was performed along with also histopathological and immunochemical examinations.
RESULTSThe in-stent minimal lumen diameter of triptolide group was significantly greater, and the neointimal area significantly smaller, than those of the control group (P<0.05). PCNA expression was significantly lower while P27(kip1) protein significantly higher in triptolide group than in the control group (P<0.05).
CONCLUSIONTriptolide-eluting stent can effectively inhibit neointimal formation to prevent restenosis in porcine coronary artery 4 weeks after implantation, probably by inhibiting P27(kip1) expression and consequently vascular smooth muscle cell proliferation.
